City
Epaper

No need of booster dose for now: AIIMS Director

By IANS | Updated: November 23, 2021 23:20 IST

New Delhi, Nov 23 All India Institute of Medical Sciences (AIIMS) Director Randeep Guleria on Tuesday said India ...

Open in App

New Delhi, Nov 23 All India Institute of Medical Sciences (AIIMS) Director Randeep Guleria on Tuesday said India does not need booster dose at this time.

Guleria said that there is no surge in cases as such at the moment which suggests that vaccines are still protecting against the coronavirus.

He said: "There is no need for a vaccine booster dose or third dose for now."

"It is unlikely that a third wave of Covid-19 of a magnitude comparable to the first and second will hit India. With time the pandemic will take an endemic form. We'll continue to get cases but the severity will be highly reduced," he added.

Dr. Guleria was speaking at the launch of a book "Going Viral: Making of Covaxin - The Inside Story" which has been authored by Indian Council of Medical Research Director General Dr Balram Bhargava.

The AIIMS director said that when H1N1 had hit India, vaccines were imported from foreign countries. "From importing vaccines to manufacturing our own indigenous vaccine, we have come a long way. Today, our Covid vaccines are being exported to other countries,"

On the need of Covid booster dose, NITI Aayog member (Health) Dr. VK Paul said the decision on a third dose should be based on science.

The book 'Going Viral...' is an attempt to take readers through the journey of developing India's first indigenous Covid-19 vaccine. The book captures the first-hand experiences of scientists who worked round the clock to develop India's first indigenous Covid-19 vaccine in a record time of less than eight months. The book sheds light on the resilience and courage depicted.

Talking about his book, Dr. Bhargava said: "The development of India's indigenous vaccine Covaxin is a true example of public private-partnership marked with trust and and transparency."

In his book, Prof (Dr.) Bhargava has also brought to the forefront some lesser-known facts behind the making of Covaxin including the innovative ways in which scientists navigated a strict nationwide lockdown to conduct India's first seroprevalence survey. In another anecdote, the author has highlighted the important role played by 20 monkeys in ensuring that millions of Ind across the country have access to this life-saving vaccine.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: V.K PaulindiaNew DelhiAll India Institute Of Medical SciencesAiimsRandeep GuleriaThe new delhi municipal councilDelhi south-westIndiUk-indiaRepublic of india
Open in App

Related Stories

NationalPM Narendra Modi Discusses Tech and Innovation Collaboration With Elon Musk

NationalTahawwur Rana Extradition: Pakistan Distances Itself From 26/11 Accused After Arrival in India

NationalIndia Expands Rafale Power: Rs 64,000 Crore Deal Cleared for Navy Fighter Jets

NationalHeatwave in India: Maharashtra, Gujarat Experience Unbearable Night and Day Time Temperature, Bengaluru Likely to Witness Rain

NationalIMD predicts Heatwave in North India For Next 6 days, Delhi to Record 42-degree Celsius

Health Realted Stories

HealthCentre extends financial aid to indigenous indoor air purification solution

HealthChildhood exposure to bacterial toxin can trigger Colorectal cancer among the young: Study

HealthIndia achieves breakthrough in gene therapy for haemophilia: Minister

LifestyleWalking Tips for Summer: Know the Best time to Walk to Avoid Heatstroke

HealthCentre launches campaign to achieve 100 pc Measles-Rubella immunisation coverage